Abstract
Since the completion of the Human Genome Project, increasing scrutiny has focused on patterns of genetic variation among global populations and their association with disease and human traits. This paper addresses emerging techniques to identify genetic differences, including admixture mapping and the use of ancestry informative markers (AIMS), towards controlling population substructure in genetic association studies. The paper discusses the need to reconcile statistical race used to determine genetic ancestry with phenotypic race in identifying and addressing ongoing health disparities among human populations. As DNA biobanking grows and standards for collecting phenotypic information are developed, clear understanding of the varied approaches to defining race and their implications will be imperative. Central to this explication will be an exploration of how genetic technologies inform current approaches to ancestry and their relevance for pharmacogenomic applications.
Keywords: DNA biobanks, genetic ancestry, health disparities, pharmacogenomics, race-based therapeutics
Current Pharmacogenomics and Personalized Medicine
Title: Defining Statistical Race and Phenotypic Race and Their Implications for Health Disparities
Volume: 7 Issue: 4
Author(s): S. S-J. Lee
Affiliation:
Keywords: DNA biobanks, genetic ancestry, health disparities, pharmacogenomics, race-based therapeutics
Abstract: Since the completion of the Human Genome Project, increasing scrutiny has focused on patterns of genetic variation among global populations and their association with disease and human traits. This paper addresses emerging techniques to identify genetic differences, including admixture mapping and the use of ancestry informative markers (AIMS), towards controlling population substructure in genetic association studies. The paper discusses the need to reconcile statistical race used to determine genetic ancestry with phenotypic race in identifying and addressing ongoing health disparities among human populations. As DNA biobanking grows and standards for collecting phenotypic information are developed, clear understanding of the varied approaches to defining race and their implications will be imperative. Central to this explication will be an exploration of how genetic technologies inform current approaches to ancestry and their relevance for pharmacogenomic applications.
Export Options
About this article
Cite this article as:
Lee S-J. S., Defining Statistical Race and Phenotypic Race and Their Implications for Health Disparities, Current Pharmacogenomics and Personalized Medicine 2009; 7 (4) . https://dx.doi.org/10.2174/187569209790112300
DOI https://dx.doi.org/10.2174/187569209790112300 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Blood Pressure Lowering and Outcomes in type 2 Diabetes: Implications of the Blood Pressure-Lowering Arm of the Advance Trial
Current Hypertension Reviews Withdrawal Notice: Mucoadhesive Microspheres: An Emerging Trends in Therapy of Diabetes Mellitus
Current Diabetes Reviews Synthetic Strategies of Benzothiazines: A Mini Review
Mini-Reviews in Organic Chemistry Antidiabetic Drugs as Antihypertensives: New Data on the Horizon
Current Vascular Pharmacology Pharmacological Treatment of Hypoxic-Ischemic Reperfusion Injury of the Newborn Brain in the Clinical Setting: What are the Possibilities in the Near Future?
Current Pediatric Reviews Modulation of Plasma Non Enzimatic Antioxidant Capacity (NEAC) by Plant Foods: the Role of Polyphenol
Current Topics in Medicinal Chemistry Angiotensin II and the Cardiac Complications of Diabetes Mellitus
Current Pharmaceutical Design Therapeutic Effects of Renal Denervation on Renal Failure
Current Neurovascular Research The Role of microRNAs in the Initiation and Progression of Stable Atheromatous Plaque
Current Pharmaceutical Design Novel Therapeutic Options in Metastatic Renal Cancer – Review and Post ASCO 2007 Update
Reviews on Recent Clinical Trials Progress Towards Clinically Useful Aldosterone Synthase Inhibitors
Current Topics in Medicinal Chemistry Ajmalicine and its Analogues Against AChE and BuChE for the Management of Alzheimer’s Disease: An <i>In-silico</i> Study
Current Pharmaceutical Design GC/MS Profile and <i>In-Vitro</i> α-Glucosidase Inhibitory Activity of Essential Oil of <i>Eucalyptus camaldulensis</i> Dehnh Collected from (Erbil) Iraq
Current Bioactive Compounds Reliability of Blood Pressure Patterns Defined by a Single 24-Hour Ambulatory Blood Pressure Monitoring: The Case of the Dipping/Non Dipping and Isolated Clinic Hypertension
Current Hypertension Reviews Editorial (Thematic Issue: Myokines and Exercise Training: More Shadows than Lights)
Current Pharmaceutical Design Tyrphostins as Potential Therapeutic Agents for Acute Kidney Injury
Current Medicinal Chemistry Role of PPAR in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Pleiotropic Effects of Nitric Oxide on SARS-CoV-2 Infections
Coronaviruses Mechanisms of Action of Metformin in Type 2 Diabetes and Associated Complications: An Overview
Mini-Reviews in Medicinal Chemistry Does Caffeine Affect Cardiovascular Responses?
Vascular Disease Prevention (Discontinued)